2 unknown, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Terminated 1 |
Follow Xeroderma Pigmentosum: new trials by email Literature Review of Xeroderma Pigmentosum trials Research Report on Xeroderma Pigmentosum
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V Afamelanotide - Xeroderma Pigmentosum | Phase 2 | Unknown | Clinuvel Europe Limited | 6 | 2022-03-28 | 2023-09-21 |
| A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP) Afamelanotide - Xeroderma Pigmentosum | Phase 2 | Unknown | Clinuvel Europe Limited | 6 | 2021-10-19 | 2023-06-18 |
| A Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC Patidegib Topical Gel, 2%, Patidegib Topical Gel, Vehicle - Recurrent Basal Cell Carcinoma | Phase 2 | Terminated | Sol-Gel Technologies, Ltd. | 50 | 2019-12-20 | 2026-07-21 |
Basal Cell Nevus Syndrome (1) · Carcinoma, Basal Cell (1) · Rombo syndrome (1) · Syndrome (1)
Congenital Abnormalities (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · DNA Repair-Deficiency Disorders (3) · Genetic Diseases, Inborn (3) · Metabolic Diseases (3) · Neoplasms (3) · Nutritional and Metabolic Diseases (3) · Photosensitivity Disorders (3) · Pigmentation Disorders (3) · Precancerous Conditions (3) · Skin Abnormalities (3) · Skin Diseases (3) · Skin Diseases, Genetic (3) · Skin and Connective Tissue Diseases (3) · Abnormalities, Multiple (1)
afamelanotide (2)
Clinuvel Europe Limited (2) · Sol-Gel Technologies, Ltd. (1)
Belgium (1) · Germany (1) · Spain (1) · United States (1)